Study of use of Ayurveda Intervention (Ayush-64) in COVID 19
Phase 2
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/06/026002
- Lead Sponsor
- ational Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients of 18-60 yrs of age, clinically diagnosed with corona virus disease 2019 by RTPCR test coming under stage I- mild (Early infection)
2.Participants who can take medicines orally.
3.Patients willing to provide signed informed consent.
Exclusion Criteria
1.Pregnant, Lactating women, patients with CKD (Chronic Kidney Disease).
2.Not willing to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical cure rate: Time to negative conversion of COVID19.Timepoint: Time to event
- Secondary Outcome Measures
Name Time Method Duration of fever and each of the respiratory symptomsTimepoint: Baseline to one month;Improvement in hematological and laboratory parameters (CBC, LFT, RFT, RBS, ESR, Hs-CRP, LDH, CXR, ABG, S. Ferritin, D-dimer, ECG)Timepoint: Baseline to one month;No of cases Reporting any ADR/AETimepoint: Baseline to one month;Number of cases that progressed to multi-organ failure while under clinical trialTimepoint: Baseline to one month;Number of cases that required invasive or non-invasive oxygen therapy during the intervention.Timepoint: Baseline to one month;Number of patients referredTimepoint: Baseline to one month